Continental Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.01M |
| 2 |
CVS Health
CVS
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.1M |
| 4 |
T. Rowe Price
TROW
|
+$1.8M |
| 5 |
JPMorgan Chase
JPM
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHMI
Cherry Hill Mortgage Investment Corp
CHMI
|
+$2.8M |
| 2 |
Provident Financial
PROV
|
+$2.48M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.94M |
| 4 |
Sanofi
SNY
|
+$1.85M |
| 5 |
KCG
KCG Holdings, Inc.
KCG
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.06% |
| 2 | Healthcare | 23.03% |
| 3 | Consumer Discretionary | 1.81% |
| 4 | Consumer Staples | 1.57% |
| 5 | Industrials | 0.95% |
Similar funds
Continental Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Continental Advisors held 153 positions worth $358M, up 10% from $324M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Continental Advisors deployed $17.4M of net new capital in Q3 2016, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was Gilead Sciences: 37,000 shares worth $2.93M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Cherry Hill Mortgage Investment Corp, an estimated $2.8M trimmed.
- Continental Advisors's largest Q3 2016 buy was Gilead Sciences: 37,000 shares worth $2.93M.
- Continental Advisors added most to CVS Health in Q3 2016, an estimated $2.4M increase.
- Continental Advisors's biggest Q3 2016 reduction was Cherry Hill Mortgage Investment Corp, cutting an estimated $2.8M.
- Continental Advisors fully exited Sanofi in Q3 2016, selling an estimated $1.85M.
- Continental Advisors's ten largest holdings make up 28% of its $358M portfolio in Q3 2016.
- Continental Advisors opened 34 new positions and closed 16 in Q3 2016.
- Continental Advisors's portfolio value rose 10% quarter-over-quarter to $358M.
Based on Continental Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.